Publication Date
In 2025 | 0 |
Since 2024 | 2 |
Descriptor
Alzheimers Disease | 2 |
Down Syndrome | 2 |
Adults | 1 |
Age Differences | 1 |
At Risk Persons | 1 |
Children | 1 |
Decision Making | 1 |
Dementia | 1 |
Diagnostic Tests | 1 |
Experience | 1 |
Foreign Countries | 1 |
More ▼ |
Author
Adrian Danek | 1 |
Catharina Prix | 1 |
Elisabeth Wlasich | 1 |
Endy Weidinger | 1 |
Gabrielle Cummings | 1 |
Georg Nübling | 1 |
Johannes Levin | 1 |
Jonathan Vöglein | 1 |
Kirsten A. Riggan | 1 |
Laura Koll | 1 |
Lennart C. Neumann | 1 |
More ▼ |
Publication Type
Journal Articles | 2 |
Reports - Research | 2 |
Education Level
Audience
Location
Germany | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Sarah Batbold; Gabrielle Cummings; Kirsten A. Riggan; Marsha Michie; Megan Allyse – Journal of Intellectual Disabilities, 2024
Individuals with Down syndrome (DS) experience increased risk of Alzheimer's disease (AD). Recent studies suggest that a vaccine against AD may be forthcoming. Parental buy-in is critical to the success of any intervention in this population, as adults with DS often rely on familial support. This study aims to characterize parents' perceptions of…
Descriptors: Parent Attitudes, Down Syndrome, Children, Alzheimers Disease
Sandra V. Loosli; Lennart C. Neumann; Elisabeth Wlasich; Catharina Prix; Laura Koll; Endy Weidinger; Jonathan Vöglein; Olivia Wagemann; Adrian Danek; Georg Nübling; Johannes Levin – Journal of Intellectual & Developmental Disability, 2024
Background: The CAMDEX-DS is an instrument to diagnose Alzheimer's disease (AD) in Down syndrome consisting of an informant interview and a cognitive test battery (CAMCOG-DS). Measurement properties of the German CAMDEX-DS were investigated. Method: Fifty-five adults with Down syndrome (19-58 years) participated in this observational study.…
Descriptors: Foreign Countries, Diagnostic Tests, Alzheimers Disease, Down Syndrome